Skip to content
VC FundAllocates capital directlyLAST VERIFIED Oct 2026 · 14 SOURCES

Siryo

Also known as Siryo SpA, Siryo S.p.A.

Bari venture capital company (SpA) using a venture-studio model to back materials-science startups in food/health, biomaterials, energy and environment; equity, convertibles, seed to expansion.

HEADQUARTERS
Bari, Italy
FOUNDED
—
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
6 people

FOCUS

STAGES
SeedSeries A
SECTORS
Biotech & Life SciencesHealthTechFood & AgricultureClimate & EnergyDeep Tech
ASSET MIX
Venture capital
GEOGRAPHY
ItalyEuropeMiddle EastAfrica

WHAT IT IS

VC Fund. A fund manager investing capital raised from limited partners into startups.

ABOUT

Siryo SpA is a Bari-based company that selects and finances research-based technologies in materials science for human and environmental health (“One-Health”), in food/health, biomaterials, energy and environment. It works as a venture studio, supporting researchers from lab to market and taking an active role in portfolio management, with a focus on Southern Europe, North Africa and the Middle East. It invests through equity, convertible loans and participative instruments at seed, start-up, spin-off and expansion stages.

INVESTMENT THESIS

“Science first”: disruptive materials-science platforms for human and environmental health, starting from Southern Italy, with structured scientific, managerial and financial support (venture-studio model).

PORTFOLIO (8)

TEAM

  • Alessandro Sannino
    Chairman · source
  • Lucio Luigi Gaita
    Vice Chairman (independent) · source
  • Paolo De Carlo
    Board member · source
  • Raffaele Bruni
    Independent board member · source
  • Katia Valerio
    Independent board member · source
  • Ercole Festa
    General Manager · source

LINKS

FAQ

Siryo is a VC fund based in Bari, Italy.

Yes. Siryo invests directly in private companies.

Siryo invests at Seed and Series A stages in Biotech & Life Sciences, HealthTech, Food & Agriculture, Climate & Energy and Deep Tech.

Siryo's stated ticket size is €500K–€10M.

Key people at Siryo include Alessandro Sannino (Chairman), Lucio Luigi Gaita (Vice Chairman (independent)), Paolo De Carlo (Board member) and Raffaele Bruni (Independent board member).

Siryo's investments include T.E.C. S.r.l., Oxoco S.r.l., Votis Subdermal Imaging Technologies, Postbiotica S.r.l., Oloker Therapeutics S.r.l., Celery S.r.l., EggPlant S.r.l. and Typeone Biomaterials S.r.l..

The most recent publicly reported investment by Siryo is Celery (€2.5M round (via Holding S1 SpA)), announced in Jan 2022.

Siryo states that it accepts submissions through its official contact page.

Yes. Siryo manages capital from outside investors.